HER2 and EGFR amplification and expression in urothelial carcinoma occurs in distinct biological and molecular contexts.
about
Different stages in drug development for muscle-invasive bladder cancer.A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort.Prognostic Value of Molecular Breast Cancer Subtypes based on Her2, ESR1, PGR and Ki67 mRNA-Expression in Muscle Invasive Bladder Cancer.
P2860
HER2 and EGFR amplification and expression in urothelial carcinoma occurs in distinct biological and molecular contexts.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
HER2 and EGFR amplification an ...... ogical and molecular contexts.
@en
type
label
HER2 and EGFR amplification an ...... ogical and molecular contexts.
@en
prefLabel
HER2 and EGFR amplification an ...... ogical and molecular contexts.
@en
P2093
P2860
P356
P1433
P1476
HER2 and EGFR amplification an ...... ogical and molecular contexts.
@en
P2093
Fredrik Liedberg
Gottfrid Sjödahl
Gunilla Chebil
Pontus Eriksson
P2860
P304
48905-48914
P356
10.18632/ONCOTARGET.16554
P407
P577
2017-03-24T00:00:00Z